Blar i forfatter "Venter, Hermoine Jean"

Viser treff 1-3 av 3

    • Alterations in genetically modified crops assessed by omics studies: Systematic review and meta-analysis 

      Benevenuto, Rafael Fonseca; Venter, Hermoine Jean; Zanatta, Caroline Bedin; Nodari, Rubens Onofre; Agapito-Tenfen, Sarah Zanon (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-01-04)
      Background: International agreements and domestic legislation regulate genetically modified (GM) crops for environmental release, recognizing that genetic engineering could result in unintended genotypic and phenotypic effects. In that context, omics technologies, which allow comprehensive characterization of the molecular profile of GM crops at all levels, may be used to assess alterations or ...

    • Alterations in genetically modified crops assessed by omics studies: Systematic review and meta-analysis 

      Benevenuto, Rafael Fonseca; Venter, Hermoine Jean; Zanatta, Caroline Bedin; Nodari, Rubens Onofre; Agapito-Tenfen, Sarah Zanon (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-01-04)
      Background International agreements and domestic legislation regulate genetically modified (GM) crops for environmental release, recognizing that genetic engineering could result in unintended genotypic and phenotypic effects. In that context, omics technologies, which allow comprehensive characterization of the molecular profile of GM crops at all levels, may be used to assess alterations or effects ...

    • The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens 

      Wolden, Runa; Ovchinnikov, Kirill; Venter, Hermoine Jean; Oftedal, Thomas; Diep, Bao Dung; Cavanagh, Jorunn Pauline (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-10-31)
      Staphylococcus haemolyticus is an increasingly relevant nosocomial pathogen. The combination of multi-drug resistance and ability to form biofilms makes S. haemolyticus infections difficult to treat. Bacteriocins are ribosomally synthesized antimicrobial peptides produced by bacteria to inhibit growth of often closely related bacteria. Due to differences in the modes of action between bacteriocins ...